IBDEI0H2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7886,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,7886,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,7886,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,7887,0)
 ;;=G31.09^^30^416^16
 ;;^UTILITY(U,$J,358.3,7887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7887,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,7887,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,7887,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,7888,0)
 ;;=G20.^^30^416^24
 ;;^UTILITY(U,$J,358.3,7888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7888,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,7888,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,7888,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,7889,0)
 ;;=G20.^^30^416^25
 ;;^UTILITY(U,$J,358.3,7889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7889,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,7889,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,7889,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,7890,0)
 ;;=G31.01^^30^416^26
 ;;^UTILITY(U,$J,358.3,7890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7890,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,7890,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,7890,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,7891,0)
 ;;=G23.1^^30^416^28
 ;;^UTILITY(U,$J,358.3,7891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7891,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,7891,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,7891,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,7892,0)
 ;;=Z79.2^^30^417^1
 ;;^UTILITY(U,$J,358.3,7892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7892,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,7892,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,7892,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,7893,0)
 ;;=Z79.01^^30^417^2
 ;;^UTILITY(U,$J,358.3,7893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7893,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,7893,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,7893,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,7894,0)
 ;;=Z79.02^^30^417^3
 ;;^UTILITY(U,$J,358.3,7894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7894,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,7894,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,7894,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,7895,0)
 ;;=Z79.82^^30^417^4
 ;;^UTILITY(U,$J,358.3,7895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7895,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,7895,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,7895,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,7896,0)
 ;;=Z79.4^^30^417^5
 ;;^UTILITY(U,$J,358.3,7896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7896,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,7896,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,7896,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,7897,0)
 ;;=Z79.1^^30^417^7
 ;;^UTILITY(U,$J,358.3,7897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7897,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,7897,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,7897,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,7898,0)
 ;;=Z79.891^^30^417^8
 ;;^UTILITY(U,$J,358.3,7898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7898,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,7898,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,7898,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,7899,0)
 ;;=Z79.51^^30^417^9
 ;;^UTILITY(U,$J,358.3,7899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7899,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,7899,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,7899,2)
 ;;=^5063335
